Project Grant R41GM154567
Award Date
6/1/25
Completion Date
5/31/26
Dollars Obligated
$295K
Federal Agency
National Institute of General Medical Sciences
Awardee
Altvivo, Inc. (LAPSDRW59387)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to 37Degrees, Inc. aims to develop a portable and modular system for long-term live cell and tissue culture imaging. The project objectives are to: 1) Enable a personal cellular video microscopy solution to democratize scientists' ability to visualize dynamic biological phenomena over extended time periods, and 2) Overcome technical limitations in maintaining cell...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Dragonase LLC in Minneapolis, MN to develop a fully autonomous robotic wet lab for optimizing hematopoietic stem cell (HSC) culture media. The project, running from June 2025 to February 2026, aims to build a "machine biologist" system consisting of a robotic wet lab and machine learning computer vision models to rapidly and...
The federal Project Grant award of $350,000 was provided by the National Center for Advancing Translational Sciences (NCATS), under the CFDA Program 93.350, to Vivosphere LLC in Auburn, AL. The funding will support the development of "Vivospheres", which are tissue-engineered spheroidal models for high-throughput screening. The project aims to establish Vivospheres as a more consistent and flexible 3D cell culture system compared to traditional self-aggregation methods, enabling...
This federal Project Grant award from the National Center for Advancing Translational Sciences (NCATS), under CFDA 93.350, provides $349,171 to Cellchorus Inc. to develop an integrated computer vision system called LF-TIMING (Label-Free TIMING). The goal is to enable large-scale, label-free profiling of cell-cell interactions, particularly between immune cells and tumor cells. The LF-TIMING system will leverage deep neural networks to accurately analyze phase-contrast video recordings,...
The National Institute of General Medical Sciences (NIGMS) awarded a $947,705 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Applied Biophysics, Inc. in Troy, NY. The grant, running from July 2024 to June 2026, aims to develop an innovative "Cell Assurance Monitor" (CAM) instrument. This device will leverage impedance-based cellular monitoring and multivariate statistical analysis to assist researchers in detecting cell line...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Vivosphere LLC for $275,000 will support the development of a novel tissue-engineered platform for cancer modeling and drug screening. The project aims to create a more physiologically relevant, high-throughput screening model to improve the translation rate between preclinical and clinical testing of anti-cancer drug candidates. The proposed technology utilizes a 3D hydrogel...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. PSM is a label-free, high-throughput imaging platform that enables real-time quantification of molecular binding kinetics on single cells in their native cellular microenvironment. The goal is to create...
This $500,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), will support research to develop an end-to-end continuous manufacturing process for cell therapies using robotics and microfluidic technologies. The Georgia Tech Research Corporation will receive funding to create a more integrated workflow based on microfluidic device-enabled genetic engineering, cell expansion, and...
The National Institutes of Health National Institute of General Medical Sciences awarded New Jersey Institute of Technology a $832,624 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to develop an automated microfluidics technology for minimally disruptive analysis of cells and fluids within living 3D cultures. The three-year project beginning July 1, 2022 aims to design a novel microfluidic plumbing architecture capable of performing thousands of XYZ...
The National Center for Advancing Translational Sciences (NCATS), through its CFDA 93.350 Federal Grant Program, awarded a $294,541 Project Grant to Cellular Vehicles Inc. on June 1, 2024. The purpose of this award is to develop an automated system for producing and delivering cell-laden hydrogel therapies. The project aims to create a novel, standardized process for formulating, encapsulating, and directly injecting cell-laden hydrogels into diseased tissues. This is intended to improve the...